Amgen Inc Drug Patent Portfolio

Amgen Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amgen Inc News

A timeline of the patent dispute between Amgen and Sanofi regarding Repatha and Praluent.

13 Mar, 2026

Amgen and Sanofi conclude their significant dispute regarding Praluent and Repatha - JUVE Patent

12 Mar, 2026

Three Generic Pharmaceutical Stocks to Monitor Amid Industry Challenges - Yahoo Finance

04 Mar, 2026

Sanofi's Wayrilz Receives Orphan Drug Designation for IgG4-Related Disease in Japan - TradingView

03 Mar, 2026

See More